Rational and uniform design of identification tests in DAB 8.4
Göber, B.; Böttger, J.; Felsing, A.; Pfeifer, S.
Die Pharmazie 27(4): 222-234
1972
ISSN/ISBN: 0031-7144 PMID: 4115398 Document Number: 51018
Document emailed within 1 workday
Related Documents
Schnur, D.M. 2008: Recent trends in library design: 'rational design' revisited Current Opinion in Drug Discovery and Development 11(3): 375-380Liu, D.; Wang, P.; Li, F.; Li, J. 1991: Application of uniform design in L-isoleucine fermentation Chinese Journal of Biotechnology 7(3): 207-212
Guo, H.-Y.; Yan, X.-P.; Yi, B.-W.; Zheng, R.; Kuang, Y. 2013: Optimization of formulas of Quban gel by uniform design Zhongguo Zhong Yao Za Zhi 38(23): 4076-4078
Wang, X.-G.; Zou, Y.-F.; Chen, Y.-Z. 2008: Optimization of matrix formulation of effective parts cataplasm of Pogostemon cablin by uniform design Zhongguo Zhong Yao Za Zhi 33(6): 638-641
Wlodawer, A. 1994: Rational drug design: the proteinase inhibitors PharmacoTherapy 14(6 Pt 2): 9S
Swiatko, J.; De Forest, P.R.; Zedeck, M.S. 2003: Further studies on spot tests and microcrystal tests for identification of cocaine Journal of Forensic Sciences 48(3): 581-585
Chang, T.T.; Chou, T.C. 2000: Rational approach to the clinical protocol design for drug combinations: a review Acta Paediatrica Taiwanica 41(6): 294-302
McCluskey, A.; Ackland, S.P.; Gardiner, E.; Walkom, C.C.; Sakoff, J.A. 2001: The inhibition of protein phosphatases 1 and 2A: a new target for rational anti-cancer drug design? Anti-Cancer Drug Design 16(6): 291-303
Wu, J.H.; Reynolds, C.A. 1996: A role for density functional calculations in the rational design of bioreductive cobalt complexes? Anti-Cancer Drug Design 11(5): 415-420
Pannall, P.; Marshall, W.; Jabor, A.; Magid, E. 1995: A strategy to promote the rational use of laboratory tests. Guideline Annales de Biologie Clinique 53(9): 515-517
Moneret-Vautrin, D.A.; Kanny, G. 2002: Anaphylaxis to muscle relaxants: rational for skin tests Allergie et Immunologie 34(7): 233-240
Lown, J.W. 1988: Lexitropsins: rational design of DNA sequence reading agents as novel anti-cancer agents and potential cellular probes Anti-Cancer Drug Design 3(1): 25-40
Guilhot, F.; Guerci, A.; Fiere, D.; Harousseau, J.L.; Maloisel, F.; Bouabdallah, R.; Guyotat, D.; Rochant, H.; Najman, A.; Nicolini, F.; Colombat, P.; Abgrall, J.F.; Ifrah, N.; Brière, J.; Bauters, F.; Navarro, M.; Morice, P.; Bordessoule, D.; Vilque, J.P.; Desablens, B.; Tertian, G.; Blanc, M.; Chastang, C.; Tanzer, J. 1996: The treatment of chronic myelogenous leukemia by interferon and cytosine-arabinoside: rational and design of the French trials. French CML Study Group Bone Marrow Transplantation 17(Suppl 3): S29-S31
Il'ina, T.B.; Trofimova, M.F.; Kachaunova, N.N.; Shappo, E.S. 1972: Identification of mycobacteria using niacin and other tests Problemy Tuberkuleza 50(11): 66-70
Karikó, K. 1995: Identification of conserved sequences for PCR primer design by multiple alignments of dot matrix plots Biotechniques 18(6): 1048-1049
Yang, H.; Yang, X.; Chen, Y.; Pan, M. 2008: Microstrip antenna design and system research of radio frequency identification temperature sensor Sheng Wu Yi Xue Gong Cheng Xue Za Zhi 25(6): 1420-1424
Krishna, S.; Kumar, V.; Siddiqi, M.Imran. 2016: Recent Advances in Computer-Assisted Structure-Based Identification and Design of Histone Deacetylases Inhibitors Current Topics in Medicinal Chemistry 16(9): 934-947
Murakami, S.; Fukuoka, Y. 1979: Cross-matching tests and identification of incomplete antibodies Rinsho Byori. Japanese Journal of Clinical Pathology Suppl 39: 99-132
Tewari, S.N.; Shukla, S.K. 1978: Studies on the identification of 1.4-benzodiazepine drugs by micro-crystal tests Die Pharmazie 33(6): 372-373
Cauich-Sanchez, P.; Alatriste-Mondragon, F.; Garcia-Cano, E.; Aquino-Santiago, C. 2001: Identification of anaerobic nonsporeforming gram-positive bacilli by biochemical tests and gas-liquid chromatography Revista Latinoamericana de Microbiologia 43(1): 27-35